OBJECTIVE: Investigate the technical success and safety of percutaneous PDA closure
during infancy. DATA SOURCES: Scopus, Web of Science, Embase, PubMed, and Ovid …

OBJECTIVES Percutaneous patent ductus arteriosus (PDA) closure is becoming the
standard of care for definitive closure in progressively smaller and younger neonates. The …

Background Patent ductus arteriosus (PDA) is common in extremely low birth weight (ELBW)
infants. The objectives of this study were to describe our early clinical experience of …

Background Percutaneous closure of patent ductus arteriosus (PDA) in term neonates is
established, but data regarding outcomes in infants born very preterm (< 32 weeks of …

The optimal management approach of the patent ductus arteriosus (PDA) in premature
infants remains uncertain owing the lack of evidence for long-term benefits and the limited …

Objective To investigate technical success and safety of percutaneous patent ductus
arteriosus closure in infants≤ 1.5 kg. Study design A systematic review and meta-analysis …

Abstract Background: The National Cardiovascular Data Registry (NCDR) launched the
IMPACT (Improving Pediatric and Adult Congenital Treatment) Registry in 2010. By 2013, its …

Objectives To describe a new technique for transcatheter patent ductus arteriosus (PDA)
closure in extremely preterm infants using commercially available technology. Background …

Objectives: The authors sought to identify risk factors associated with major adverse events
(MAEs) in infants< 6 kg undergoing transcatheter patent ductus arteriosus (PDA) occlusion …

To evaluate short-term procedural outcomes and safety for infants< 2.5 kg who underwent
catheterization with intended patent ductus arteriosus (PDA) device closure in a multi-center …